Amol Kulkarni to Humans
This is a "connection" page, showing publications Amol Kulkarni has written about Humans.
Connection Strength
0.029
-
Balasubramanian A, Pilankatta R, Teramoto T, Sajith AM, Nwulia E, Kulkarni A, Padmanabhan R. Inhibition of dengue virus by curcuminoids. Antiviral Res. 2019 02; 162:71-78.
Score: 0.007
-
Xu Q, Kulkarni AA, Sajith AM, Hussein D, Brown D, G?ner OF, Reddy MD, Watkins EB, Lass?gue B, Griendling KK, Bowen JP. Design, synthesis, and biological evaluation of inhibitors of the NADPH oxidase, Nox4. Bioorg Med Chem. 2018 03 01; 26(5):989-998.
Score: 0.006
-
Balasubramanian A, Teramoto T, Kulkarni AA, Bhattacharjee AK, Padmanabhan R. Antiviral activities of selected antimalarials against dengue virus type 2 and Zika virus. Antiviral Res. 2017 01; 137:141-150.
Score: 0.006
-
Kumari N, Kulkarni AA, Lin X, McLean C, Ammosova T, Ivanov A, Hipolito M, Nekhai S, Nwulia E. Inhibition of HIV-1 by curcumin A, a novel curcumin analog. Drug Des Devel Ther. 2015; 9:5051-60.
Score: 0.005
-
Fortunak JM, de Souza RO, Kulkarni AA, King CL, Ellison T, Miranda LS. Active pharmaceutical ingredients for antiretroviral treatment in low- and middle-income countries: a survey. Antivir Ther. 2014; 19 Suppl 3:15-29.
Score: 0.005